Methods	RCT.
Participants	Setting: 102 women in a Cairo hospital, Egypt. Inclusion criteria: women at term (> 37 weeks’ gestation) scheduled for induction, singleton viable fetus, intact membranes, no uterine contractions Exclusion criteria: malpresentation, placenta previa, previous uterine surgery, contraindications to induction
Interventions	Intervention group: self-administered IMN, 40 mg, 3 doses 12 hrs apart (scheduled for 36, 24 and 12 hrs before induction Comparison group: placebo same regiment as intervention group
Outcomes	CS, further induction agents required, PPH, Apgar score >7 at 5mins, NICU admission, side effects
Notes
Risk of bias
Item	Authors’ judgement	Description
Adequate sequence generation?	Yes	Computer generated sequence.
Allocation concealment?	Yes	Coded treatment packs prepared by pharmacy.
Blinding? Women	Yes	Placebo controlled trial.
Blinding? Clinical staff	Yes
Incomplete outcome data addressed? All outcomes	Yes	All women randomised appear to be accounted for in the analysis